Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes [Phase 3]
Phase 3 study evaluating two doses of dulaglutide (LY2189265) in Japanese patients with Type 2 diabetes, with results posted after completio…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Efficacy Assessment of Chinese Herbal Medicine Jiangtang Tiaozhi Recipe Treating Participants With Glucose and Lipid Metabolism Disturbances [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing the efficacy of Jiangtang Tiaozhi Recipe, a Chinese herbal medicine, for glucose and lipid metabolism dis…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Afrezza® Dosing Optimization Study [Phase 4]
Phase 4 trial update on Afrezza dosing optimization completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing oral semaglutide to placebo in adults with Type 2 diabetes has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Aloe Vera Versus Thyme Honey Mouthwash in Management of Xerostomia in Type 2 Diabetics [Phase 3]
Phase 3 clinical trial comparing Aloe Vera versus Thyme Honey mouthwash for management of xerostomia in type 2 diabetics.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2023-09-13EMA Authorised: Tandemact (pioglitazone;glimepiride) — CHEPLAPHARM Arzneimittel GmbH
EMA has authorised Tandemact (pioglitazone; glimepiride) for type 2 diabetes mellitus under CHEPLAPHARM Arzneimittel GmbH.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Diabetes Management in Low-Income Hispanic Patients [Phase 2]
Phase 2 clinical trial update focusing on diabetes management in low-income Hispanic patients with type 2 diabetes.
-
FDA approval · 2023-09-12FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JARDIANCE (empagliflozin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2023-09-12FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a fixed-dose combination tablet of dapagliflozin and metformin hydrochl…
-
FDA approval · 2023-09-12FDA Approved: STEGLATRO — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Steglatro (ertugliflozin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2023-09-12FDA Approved: SEGLUROMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Segluromet, a fixed-dose combination of ertugliflozin and metformin hydrochloride by Merck S…
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial of Atenas Association for Type II diabetes mellitus and hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial investigating Egito Association for Type II diabetes mellitus and hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults [NA]
A completed clinical trial assessing the impact of acetaminophen on the performance of the Guardian Sensor (3) in adults with diabetes.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"
A completed clinical trial survey study evaluating long-term use of trelagliptin tablets in patients with type 2 diabetes mellitus; results …
-
EMA approval · 2023-08-28EMA Authorised: Actos (pioglitazone hydrochloride) — CHEPLAPHARM Arzneimittel GmbH
EMA authorises Actos (pioglitazone hydrochloride) for diabetes mellitus type 2 through CHEPLAPHARM Arzneimittel GmbH.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial exploring nitazoxanide as adjuvant therapy in type 2 diabetes mellitus; current status unknown.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography [Phase 3]
Phase 3 trial updates on dapagliflozin examining effects on coronary calcium and epicardial fat using Cardio tomography.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update evaluating the impact of renin-angiotensin-system blockade on urinary free light chains in patients with type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus [Phase 4]
A Phase 4 trial analyzed how chronic kidney disease affects clopidogrel in patients with type 2 diabetes, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Targeting Physical Activity to Improve Cardiovascular Health in Type 2 Diabetes [NA]
A completed clinical trial evaluating the impact of targeted physical activity to improve cardiovascular health in people with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Pistachios Blood Sugar Control, Heart and Gut Health [Phase 2]
Phase 2 clinical trial evaluating pistachios for blood sugar control, heart, and gut health in adults with type 2 diabetes and cardiovascula…
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Behavioral Economics Applications to Geriatrics Leveraging EHRs R33 Trial [NA]
Completed clinical trial evaluating behavioral economics applications to geriatrics using EHRs; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial [Phase 4]
Phase 4 pragmatic randomized trial comparing once-weekly semaglutide to standard of care in real-world US adults with type 2 diabetes has co…
-
CLINICAL_TRIALS withdrawal · 2023-08-15Clinical Trial Update: Pioglitazone and Insulin Resistance in ADT [Phase 3]
Phase 3 trial evaluating pioglitazone for insulin resistance in the context of androgen deprivation therapy for prostate cancer has been wit…